Changes

Jump to: navigation, search

Chronic myelomonocytic leukemia

2 bytes added, 13:06, 20 May 2018
m
Text replacement - "http://onlinelibrary.wiley.com" to "https://onlinelibrary.wiley.com"
![[Levels_of_Evidence#Evidence|Evidence]]
|-
|[httphttps://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2010.08235.x/full Grövdal et al. 2010]
|style="background-color:#91cf61"|Phase II
|-
===References===
# Grövdal M, Karimi M, Khan R, Aggerholm A, Antunovic P, Astermark J, Bernell P, Engström LM, Kjeldsen L, Linder O, Nilsson L, Olsson A, Holm MS, Tangen JM, Wallvik J, Oberg G, Hokland P, Jacobsen SE, Porwit A, Hellström-Lindberg E. Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy. Br J Haematol. 2010 Aug;150(3):293-302. Epub 2010 May 20. [httphttps://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2010.08235.x/full link to original article] '''contains verified protocol''' [https://www.ncbi.nlm.nih.gov/pubmed/20497178 PubMed] content property of [http://hemonc.org HemOnc.org]
[[Category:Chronic myelomonocytic leukemia regimens]]
[[Category:Disease-specific pages]]
[[Category:Myeloproliferative neoplasms]]
LookupUsers, editors, emailconfirmed, Administrators
14,670
edits

Navigation menu